Trial Profile
Role of Intraoperative Thymoglobulin in Decreasing Ischemia-Reperfusion Injury in Pediatric Heart Transplant Recipients
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase III
Latest Information Update: 24 Aug 2013
Price :
$35
*
At a glance
- Drugs Antithymocyte globulin (Primary)
- Indications Heart transplant rejection; Reperfusion injury
- Focus Biomarker; Therapeutic Use
- 03 Jul 2013 New trial record